Japanese clinical practice guideline for diabetes 2019
E Araki, A Goto, T Kondo, M Noda, H Noto… - Diabetology …, 2020 - Springer
The current guideline represents the 6th edition of the “Japanese Clinical Practice Guideline
for Diabetes” which has been revised every three years since its first appearance in 2004 to …
for Diabetes” which has been revised every three years since its first appearance in 2004 to …
[HTML][HTML] 2021 clinical practice guidelines for diabetes mellitus in Korea
Abstract The Committee of Clinical Practice Guidelines of the Korean Diabetes Association
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …
[PDF][PDF] 中国2 型糖尿病防治指南(2013 年版)
翁建平 - 中华糖尿病杂志, 2014 - meditool.cn
随着经济高速发展和工业化进程的加速, 生活方式的改变和老龄化进程的加速,
使我国糖尿病的患病率正呈快速上升的趋势, 成为继心脑血管疾病, 肿瘤之后另一个严重危害 …
使我国糖尿病的患病率正呈快速上升的趋势, 成为继心脑血管疾病, 肿瘤之后另一个严重危害 …
Pharmacotherapy of type 2 diabetes: An update and future directions
A DeMarsilis, N Reddy, C Boutari, A Filippaios… - Metabolism, 2022 - Elsevier
Abstract Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and
social impact for which multiple conventional and novel pharmacotherapies are currently …
social impact for which multiple conventional and novel pharmacotherapies are currently …
Type-2 diabetes mellitus and cardiovascular disease
RJ Henning - Future cardiology, 2018 - Taylor & Francis
The global prevalence of diabetes has risen in adults from 4.7% in 1980 to 8.5% in 2014. 90–
95% of adults with diabetes have Type 2 diabetes (T2D). This paper focuses on the …
95% of adults with diabetes have Type 2 diabetes (T2D). This paper focuses on the …
Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents
A Di Pino, RA DeFronzo - Endocrine reviews, 2019 - academic.oup.com
Patients with type 2 diabetes mellitus (T2DM) are at high risk for macrovascular
complications, which represent the major cause of mortality. Despite effective treatment of …
complications, which represent the major cause of mortality. Despite effective treatment of …
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the …
SE Inzucchi, RM Bergenstal, JB Buse… - Diabetes …, 2015 - Am Diabetes Assoc
In 2012, the American Diabetes Association (ADA) and the European Association for the
Study of Diabetes (EASD) published a position statement on the management of …
Study of Diabetes (EASD) published a position statement on the management of …
Pharmacological management of obesity: an endocrine Society clinical practice guideline
Objective: To formulate clinical practice guidelines for the pharmacological management of
obesity. Participants: An Endocrine Society-appointed Task Force of experts, a …
obesity. Participants: An Endocrine Society-appointed Task Force of experts, a …
Japanese clinical practice guideline for diabetes 2016
M Haneda, M Noda, H Origasa, H Noto, D Yabe… - Diabetology …, 2018 - Springer
Since its inception in 2004, the “Clinical Practice Guidelines for the Treatment of Diabetes”
has attempted to promote evidence-based, rational, efficient and standardized clinical …
has attempted to promote evidence-based, rational, efficient and standardized clinical …
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - Diabetologia, 2015 - Springer
Diabetologia (2015) 58: 429–442 DOI 10.1007/s00125-014-3460-0 management of
hyperglycaemia in patients with type 2 diabetes [1, 2]. This was needed because of an …
hyperglycaemia in patients with type 2 diabetes [1, 2]. This was needed because of an …